178 related articles for article (PubMed ID: 34289746)
1. Reduced DAPK1 Expression Promotes Stem Cell-Like Characteristics of Prostate Cancer Cells by Activating ZEB1 via Hippo/YAP Signaling Pathway.
Nong S; Wei Z; Wang Z; Ma L; Guan Y; Ni J
Stem Cells Dev; 2021 Sep; 30(18):934-945. PubMed ID: 34289746
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells.
Pérez G; López-Moncada F; Indo S; Torres MJ; Castellón EA; Contreras HR
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760173
[TBL] [Abstract][Full Text] [Related]
4. HN1L promotes stem cell-like properties by regulating TGF-β signaling pathway through targeting FOXP2 in prostate cancer.
Nong S; Wang Z; Wei Z; Ma L; Guan Y; Ni J
Cell Biol Int; 2022 Jan; 46(1):83-95. PubMed ID: 34519127
[TBL] [Abstract][Full Text] [Related]
5. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
[No Abstract] [Full Text] [Related]
6. Decrease of ZEB1 expression inhibits the B16F10 cancer stem-like properties.
Zhao F; He X; Wang Y; Shi F; Wu D; Pan M; Li M; Wu S; Wang X; Dou J
Biosci Trends; 2015 Oct; 9(5):325-34. PubMed ID: 26559025
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
8. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
[TBL] [Abstract][Full Text] [Related]
9. ZEB1 promotes prostate cancer proliferation and invasion through ERK1/2 signaling pathway.
Song XF; Chang H; Liang Q; Guo ZF; Wu JW
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4032-4038. PubMed ID: 29028100
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines.
Orellana-Serradell O; Herrera D; Castellon EA; Contreras HR
Asian J Androl; 2018; 20(3):294-299. PubMed ID: 29271397
[TBL] [Abstract][Full Text] [Related]
12. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
Zhang G; Tian X; Li Y; Wang Z; Li X; Zhu C
Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
[TBL] [Abstract][Full Text] [Related]
13. ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis and progression of prostate cancer by sponging miR-4739 to upregulate MEF2D.
Wang X; Chen Q; Wang X; Li W; Yu G; Zhu Z; Zhang W
Biomed Pharmacother; 2020 Feb; 122():109557. PubMed ID: 31918265
[TBL] [Abstract][Full Text] [Related]
14. Zinc-finger E-box-binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib.
Nurwidya F; Takahashi F; Winardi W; Tajima K; Mitsuishi Y; Murakami A; Kobayashi I; Nara T; Hashimoto M; Kato M; Hidayat M; Suina K; Hayakawa D; Asao T; Ko R; Shukuya T; Yae T; Shimada N; Yoshioka Y; Sasaki S; Takahashi K
Thorac Cancer; 2021 May; 12(10):1536-1548. PubMed ID: 33764690
[TBL] [Abstract][Full Text] [Related]
15. Effect of downregulation of ZEB1 on vimentin expression, tumour migration and tumourigenicity of melanoma B16F10 cells and CSCs.
Dou J; He X; Liu Y; Wang Y; Zhao F; Wang X; Chen D; Shi F; Wang J
Cell Biol Int; 2014 Apr; 38(4):452-61. PubMed ID: 24339410
[TBL] [Abstract][Full Text] [Related]
16. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.
Al-Marsoummi S; Vomhof-DeKrey E; Basson MD
Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790
[TBL] [Abstract][Full Text] [Related]
17. CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling.
Lai CJ; Lin CY; Liao WY; Hour TC; Wang HD; Chuu CP
Cells; 2019 Mar; 8(4):. PubMed ID: 30935014
[TBL] [Abstract][Full Text] [Related]
18. Effect of ZEB1 Associated with microRNAs on Tumor Stem Cells in Head and Neck Cancer.
Ferreira LAM; Bezerra MADS; Kawasaki-Oyama RS; Fernandes GMM; Castanhole-Nunes MMU; Serafim Junior V; Castilho RM; Pavarino ÉC; Maniglia JV; Goloni-Bertollo EM
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982993
[TBL] [Abstract][Full Text] [Related]
19. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway.
Erdogan S; Turkekul K; Dibirdik I; Doganlar O; Doganlar ZB; Bilir A; Oktem G
Biomed Pharmacother; 2018 Nov; 107():793-805. PubMed ID: 30142541
[TBL] [Abstract][Full Text] [Related]
20. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
[Next] [New Search]